Kim Yen Nguyen, MD
Rheumatology · Cincinnati, OHNPI 1801147392
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 473 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $4,234, more than ten times the $213 reported in 2023.
Across 473 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$1K
- AstraZeneca$892
- Johnson & Johnson$882
- UCB, Inc.$497
- Novartis$358
- plus $1K from 15 others
What the payments were for
- Food & beverage$8,12896%
- Education$3044%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 174 | $3,067 |
| Amgen | 64 | $1,247 |
| AstraZeneca(2 entities) | 37 | $892 |
| Johnson & Johnson | 52 | $882 |
| UCB, Inc. | 32 | $497 |
| Novartis | 38 | $358 |
| Lilly USA, LLC | 22 | $338 |
| Mallinckrodt Hospital Products Inc. | 10 | $313 |
| Organon | 10 | $167 |
| Almatica Pharma LLC | 6 | $119 |
| GSK | 6 | $100 |
| Radius Health, Inc. | 5 | $98 |
| Pfizer | 4 | $92 |
| Aurinia Pharma U.S., Inc. | 4 | $75 |
| Fresenius Kabi USA, LLC | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Bioventus LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $19 |
| Medtronic | 1 | $16 |
| Sandoz | 1 | $15 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,432 in reported general payments places this provider in the 75th percentile of 255 rheumatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 54 | $2,263 |
| Colchicine | 17 | $1,563 |
| MethotrexateMethotrexate Sodium | 50 | $1,177 |
| Hydroxychloroquine Sulfate | 53 | $1,096 |
| Leflunomide | 20 | $976 |
| Prednisone | 119 | $788 |
| Gabapentin | 26 | $286 |
| Cyclobenzaprine Hcl | 26 | $285 |
| Omeprazole | 21 | $242 |
| Sulfasalazine | 14 | $216 |
| Allopurinol | 20 | $162 |
| Methylprednisolone | 18 | $162 |
| Alendronate Sodium | 16 | $82 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Cincinnati
- Gregory DelorenzoCincinnati$1.3M
- Robert HiltzCincinnati$165K
- David GreenblattCincinnati$56K
- Michael LuggenCincinnati$13K
- Emily BowersCincinnati$10K
- John HarleyCincinnati$9K
- Leonard CalabreseCleveland$1.9M
- Alexa MearaColumbus$426K
- Chad DealCleveland$375K
- David MandelMayfield Village$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.